VLife Revisiting Shelf Computational research service

Home | Careers | Contact us

Products

Technology

Services

About us

SERVICES NEWS

Sun Pharma
enters into agreement with VLife

PRODUCTS NEWS

ReViva
Revisiting shelved compounds to unlock value

Years of research have resulted in compounds that have been shelved for multiple reasons. The research investment therein brings down the research productivity of the organization.

If you have compounds which have been shelved due to reasons of suboptimal efficacy or unacceptable toxicity, we can help you explore their potential to bring them into productive research pipeline. We have developed robust discovery approaches that we deploy depending on the nature of the shelved compound and in short time provide you with a 'go - no go' decision.

This research is carried out by expert VLife scientists who have a sterling track record in discovery of new indications and is enabled by our computational technologies and a multi core parallel processing computational cluster.

We cover the following work-flow with the scope of engagement with client covering some or all of the following steps:

Computational discovery research
Novelty search and provisional patent filing
In-vitro testing & lead optimization
Full application filing under PCT
Assignment of the filed patent to the client

Connect with VLife Expert to know more about this offering and how VLife can create intellectual property for you.

VLife services track record

VLife’s research team has over 300 man years of research experience. VLife Research Services is credited with:

  •  Design and discovery of 3 NCEs
  •  7 new indication discoveries
  •  Several activity specific research

ReViva Case studies

• To find revival opportunities for a
withdrawn/discontinued drug

Download here

THE VLIFE SERVICES ADVANTAGE

Our expertise in computational discovery
Success with computation technology requires awareness of not only its strengths but also of the areas where it needs augmentation from other approaches. Being developers of computational technologies, we have proved our expertise by creating IP in 3 NCE classes and 7 new indication discoveries.

Wide diversity of experience
We cater to a variety of sectors and within them, a diversity of areas. e.g. in pharmaceuticals, we have successfully delivered discovery projects in oncology, anti-fungal, diabetes, CNS etc.

State-of-art technology portfolio
Clients benefit from the whole range of VLife's technologies having validated algorithms, published innovations and efficient workflows which are accessible to clients through VLife services.

In-house custom development skills
Generic technologies sometimes are inadequate or inefficient in complex research. For such needs, our in-house team has skills to develop custom technologies ensuring reliable research.

Case studies: VLife services